(Q48189129)

9 February 2018

title

Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study (English)

1 reference

9 February 2018

0 references

Devine ME

1

1 reference

9 February 2018

Fonseca JA

2

1 reference

9 February 2018

Walker RW

3

1 reference

9 February 2018

Sikdar T

4

1 reference

9 February 2018

Stevens T

5

1 reference

9 February 2018

Walker Z

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 November 2007

1 reference

9 February 2018

International Journal of Geriatric Psychiatry

published in

1 reference

9 February 2018

volume

22

1 reference

9 February 2018

issue

11

1 reference

9 February 2018

page(s)

1120-1126

1 reference

9 February 2018

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations

cites work

1 reference

Cholinergic dysfunction in diseases with Lewy bodies.

21 January 2018

1 reference

A new rating scale for age-related white matter changes applicable to MRI and CT.

21 January 2018

1 reference

Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

7 January 2021

Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease

1 reference

7 January 2021

Cholinesterase inhibitors and vascular dementia: another string to their bow?

1 reference

7 January 2021

Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease.

1 reference

7 January 2021

Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors

1 reference

7 January 2021

1 reference

7 January 2021

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation

1 reference

7 January 2021

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1 reference

7 January 2021

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

7 January 2021

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

1 reference

7 January 2021

Natural history of frontotemporal dementia: comparison with Alzheimer's disease.

1 reference

7 January 2021

Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.

1 reference

7 January 2021

Absence of cholinergic deficits in "pure" vascular dementia.

1 reference

7 January 2021

Cholinergic dysfunction in vascular dementia

1 reference

7 January 2021

Pathological verification of ischemic score in differentiation of dementias.

1 reference

7 January 2021

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

1 reference

7 January 2021

The age gap between patients in clinical studies and in the general population: a pitfall for dementia research

1 reference

7 January 2021

A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.1799

1 reference

9 February 2018

1 reference

9 February 2018